Europe - Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Genital Secretions Substudy II

Completed

• Conditions: Human immunodeficiency virus (HIV); Infections and Infestations; Human immunodeficiency virus [HIV] disease

• Registration Number: ISRCTN57333945
• Lead Sponsor: Medical Research Council [MRC] Clinical Trials Unit (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-08-13
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Have been enrolled and are being followed as part of the main EARNEST trial
2. Have provided written informed consent to participate in this EARNEST substudy
3. Patients should be on the treatment regimen assigned at randomisation

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified